US Stock MarketDetailed Quotes

BCLI Brainstorm Cell Therapeutics

Watchlist
  • 1.250
  • +0.010+0.81%
Close Nov 22 16:00 ET
  • 1.270
  • +0.020+1.59%
Post 19:58 ET
7.13MMarket Cap-362P/E (TTM)

Brainstorm Cell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Brainstorm Cell Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Brainstorm Cell Therapeutics Earnings Reports

  • Brainstorm Cell Therapeutics | 8-K: BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 14 16:51 ET

  • Brainstorm Cell Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:46 ET

  • Brainstorm Cell Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 08:05 ET

  • Brainstorm Cell Therapeutics | 8-K: BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 14 07:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data